These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33775397)

  • 1. Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle.
    Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB
    Fertil Steril; 2021 Aug; 116(2):546-557. PubMed ID: 33775397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies.
    Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB
    Endocrinology; 2019 Oct; 160(10):2298-2313. PubMed ID: 31211369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome.
    Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):567-577. PubMed ID: 36372988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.
    Kristensen SG; Kumar A; Mamsen LS; Kalra B; Pors SE; Bøtkjær JA; Macklon KT; Fedder J; Ernst E; Hardy K; Franks S; Andersen CY
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3374-e3383. PubMed ID: 35511085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.
    Kissell KA; Danaher MR; Schisterman EF; Wactawski-Wende J; Ahrens KA; Schliep K; Perkins NJ; Sjaarda L; Weck J; Mumford SL
    Hum Reprod; 2014 Aug; 29(8):1764-72. PubMed ID: 24925522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis.
    Shamsa A; Gilchrist RB; Robertson DM; Rodgers RJ; Donoghoe MW; Ledger WL; Abbott JA; Riepsamen AH
    Reprod Sci; 2023 May; 30(5):1521-1527. PubMed ID: 36380138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterisation of growth differentiation factor 9 (gdf9) and bone morphogenetic protein 15 (bmp15) and their patterns of gene expression during the ovarian reproductive cycle in the European sea bass.
    Halm S; Ibañez AJ; Tyler CR; Prat F
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):95-103. PubMed ID: 18423979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 9 and bone morphogenetic protein 15 expression in previtellogenic oocytes and during early embryonic development of Yellow-tail Kingfish Seriola lalandi.
    Palomino J; Herrera G; Dettleff P; Martínez V
    Biol Res; 2014 Nov; 47(1):60. PubMed ID: 25723449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep.
    Juengel JL; Hudson NL; Heath DA; Smith P; Reader KL; Lawrence SB; O'Connell AR; Laitinen MP; Cranfield M; Groome NP; Ritvos O; McNatty KP
    Biol Reprod; 2002 Dec; 67(6):1777-89. PubMed ID: 12444053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
    Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day.
    Gnoth C; Roos J; Broomhead D; Schiffner J; Godehardt E; Freundl G; Johnson S
    Fertil Steril; 2015 Dec; 104(6):1535-43.e1-4. PubMed ID: 26384163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Bone Morphogenetic Protein 15 Polymorphisms to Predict Ovarian Stimulation Outcomes in Infertile Brazilian Women.
    Peluso C; Goldman C; Cavalcanti V; Gastaldo G; Trevisan CM; Christofolini DM; Barbosa CP; Bianco B
    Genet Test Mol Biomarkers; 2017 May; 21(5):328-333. PubMed ID: 28410456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oocyte expression, secretion and somatic cell interaction of mouse bone morphogenetic protein 15 during the peri-ovulatory period.
    Mester B; Ritter LJ; Pitman JL; Bibby AH; Gilchrist RB; McNatty KP; Juengel JL; McIntosh CJ
    Reprod Fertil Dev; 2015 Jun; 27(5):801-11. PubMed ID: 24548471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9.
    Kedem A; Fisch B; Garor R; Ben-Zaken A; Gizunterman T; Felz C; Ben-Haroush A; Kravarusic D; Abir R
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1246-54. PubMed ID: 21632818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bone Morphogenetic Protein 15 Up-Regulates the Anti-Müllerian Hormone Receptor Expression in Granulosa Cells.
    Pierre A; Estienne A; Racine C; Picard JY; Fanchin R; Lahoz B; Alabart JL; Folch J; Jarrier P; Fabre S; Monniaux D; di Clemente N
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2602-11. PubMed ID: 27070094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of active immunization against growth differentiation factor 9 and/or bone morphogenetic protein 15 on ovarian function in cattle.
    Juengel JL; Hudson NL; Berg M; Hamel K; Smith P; Lawrence SB; Whiting L; McNatty KP
    Reproduction; 2009 Jul; 138(1):107-14. PubMed ID: 19439562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization against the proregions of GDF9 or BMP15 alters ovulation rate and litter size in mice.
    McIntosh CJ; Lawrence S; Smith P; Juengel JL; McNatty KP
    Reproduction; 2012 Feb; 143(2):195-201. PubMed ID: 22106408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.